Wakefit's DRHP positions the sleep brand as a profitable D2C anomaly

Wakefit's IPO filing with SEBI in 2025 makes the Bengaluru sleep-and-home brand one of the very few D2C companies to approach public markets with a genuine profitability story rather than a promise of future profits. Founded by Ankit Garg and Chaitanya Ramalingegowda in 2016, Wakefit has taken a deliberately measured approach to growth - avoiding the brand-building spend arms race that pushed many of its D2C peers into persistent losses - and has built a business that generates operating profit while continuing to grow at a pace that justifies the public-market attention. The product portfolio spans memory-foam and orthopaedic mattresses, pillows, bed frames, wardrobes and a growing range of home-furnishing accessories. The company has a manufacturing facility in Bengaluru and has invested in its own delivery and installation capabilities for the large-format products that require in-home setup. This vertical integration, similar in structure to Lenskart's approach in eyewear, has enabled margin preservation that pure-outsourced D2C models struggle to maintain as they scale. Wakefit's customer acquisition model is notable for its relative restraint. Rather than spending heavily on broad performance marketing, the company has built much of its growth on word-of-mouth referrals, high-intent search traffic and a trials programme that allows customers to sleep on a mattress for a hundred nights before committing. This approach has produced a customer base with high satisfaction scores and strong repeat purchasing in the home category, where the replacement cycle for a mattress is long but adjacent purchases in pillows, bedding and furniture are more frequent. The DRHP filing has attracted attention from the investment community as a potential template for D2C listings going forward. The narrative is straightforward: profitable business, clear unit economics, defensible product category and a founder team that has chosen capital efficiency over speed. If the IPO prices well and the stock performs in the aftermarket, it could unlock a wave of similar filings from D2C companies that have been waiting for a credible comparable. What to watch: the final valuation at which the IPO prices relative to comparable listed consumer companies, how Wakefit's EBITDA margins trend as marketing spend normalises post-IPO, and whether the product expansion into sofas, study furniture and kitchen products can be executed without diluting the unit-economics discipline that has defined the business to date. The performance of Wakefit's retail stores in Tier-2 cities will be an early indicator of whether the sleep-wellness premium translates beyond the top-eight metro markets.

Original source: Mint